Adverse effects of vitamin E by induction of drug metabolism

Genes and Nutrition

Volumn 2, Issue 3, 2007, Pages 249-256

  Brigelius Flohé, Regina ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Adverse effects; Cardiovascular disease; Clinical trial; Drug metabolism; Interference with drug metabolism; Vitamin E

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA CAROTENE; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CYTOCHROME P450 3A4; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; ORAL ANTIDIABETIC AGENT; RETINOL; SELENIUM; WARFARIN; XENOBIOTIC AGENT;

ARTICLE; BLEEDING; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; DRUG TREATMENT FAILURE; ENZYME INDUCTION; HEART FAILURE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LUNG CANCER; NEOPLASM; NONHUMAN; OBSERVATIONAL STUDY; PHARMACOGENOMICS; RESPIRATORY TRACT INFECTION; RISK BENEFIT ANALYSIS; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; VITAMIN SUPPLEMENTATION; XENOBIOTIC METABOLISM;

RODENTIA;

EID: 38349016557     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-007-0055-0     Document Type: Article

References (80)

1. Antoniadi G, Eleftheriadis T, Liakopoulos V, Kakasi E, Vayonas G, Kortsaris A, Vargemezis V (2005) Effect of 1 year oral alpha-Tocopherol administration on anticardiolipin antibodies in heamodialysis patients. Ren Fail 27:193-198
2. ATBC prevention study group (1994) The effect of vitamin E and beta-Carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029-1035
3. Baggott JE (2005) Comment on: high-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med 143:155-156 author reply 156-158
4. Birringer M, Drogan D, Brigelius-Flohé R (2001) Tocopherols are metabolized in HepG2 cells by side chain (omega oxidation and consecutive beta-oxidation. Free Radic Biol Med 31:226-232
5. Birringer M, Pfluger P, Kluth D, Landes N, Brigelius-Flohé R (2002) Identities and differences in the metabolism of tocotrienols and tocopherols in HepG2 cells. J Nutr 132:3113-3118
6. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C (2004) Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 364:1219-1228
7. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C 2007 Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297:842-857
8. Blatt DH, Pryor WA 2005 Comment on: high-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med 143:150-151 author reply 156-158
9. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, Yang CS, Zheng SF, Gail M, Li GY et al (1993) Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85:1483-1492
10. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS (2000) Secondary prevention with antioxidants of cardiovascular disease in end-stage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356:1213-1218
11. Bowry VW, Stocker R (1993) Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 115:6029-6044
12. Brigelius-Flohé R, Kelly FJ, Salonen J, Neuzil J, Zingg J-M, Azzi A (2002) The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 76:703-716
13. Brigelius-Flohé R (2003) Vitamin E and drug metabolism. Biochem Biophys Res Commun 305:737-740
14. Brigelius-Flohé R (2005) Induction of drug metabolizing enzymes by vitamin E. J Plant Physiol 162:797-802
15. Brigelius-Flohé R (2006) Bioactivity of vitamin E. Nutr Res Rev 19:174-186
16. Bruno RS, Ramakrishnan R, Montine TJ, Bray TM, Traber MG (2005) α-Tocopherol disappearance is faster in cigarette smokers and is inversely related to their ascorbic acid status. Am J Clin Nutr 81:95-103
17. Bruno RS, Leonard SW, Atkinson J, Montine TJ, Ramakrishnan R, Bray TM, Traber MG (2006) Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation. Free Rad Biol Med 40:689-697
18. Carter T (2005) Comment on: high-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med 143:155 author reply 156-158
19. Cholerton S, Daly AK, Idle JR (1992) The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends Pharmacol Sci 13:434-439
20. Collaborative group of the primary prevention project (2001) Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 357:89-95
21. DeZee KJ, Shimeall W, Douglas K, Jackson JL (2005) Comment on: high-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med 143:153-154 author reply 156-158
22. Eidelman RS, Hollar D, Hebert PR, Lamas GA, Hennekens CH (2004) Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med 164:1552-1556
23. GISSI Gruppo Italiano per 1o Studio della Soprawivenza nell'Infarto miocardico (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354:447-455
24. Graat JM, Schouten EG, Kok FJ (2007) Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons. JAMA 288:715-721
25. Guengerich FP (1999) Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 39:1-17
26. Hayden KM, Welsh-Bohmer KA, Wengreen HJ, Zandi PP, Lyketsos CG, Breitner JC (2007) Risk of mortality with vitamin E supplements: the Cache county study. Am J Med 120:180-184
27. Hemila H (2005) Comment on: high-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med 143:151-152 author reply 156-158
28. Hooper L, Ness AR, Smith GD (2001) Antioxidant strategy for cardiovascular diseases. Lancet 357:1705-1706
29. HOPE study investigators (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 342:154-160
30. HOPE and HOPE-TOO trial investigators (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293:1338-1347
31. Ikeda S, Tohyama T, Yamashita K (2002) Dietary sesame seed and its lignans inhibit 2,7,8-trimethyl-2 (2′-carboxyethyl)-6-hydroxychroman excretion into urine of rats fed gamma-Tocopherol. J Nutr 132:961-966
32. Ioannides C (2002) Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 32:451-478
33. Jialal I, Traber MG, Devaraj S (2001) Is there a vitamin E paradox? Curr Op Lipidiol 12:49-53
34. Jialal I, Devaraj S (2005) Comment on: high-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med 143:155 author reply 156-158
35. Kaneko K, Kiyose C, Ueda T, Ichikawa H, Igarashi O (2000) Studies of the metabolism of a alpha-Tocopherol stereoisomers in rats using [5-methyl-(14)C]SRR- and RRR-alpha-Tocopherol. J Lipid Res 41:357-367
36. Kiyose C, Saito H, Kaneko K, Hamamura K, Tomioka M, Ueda T, Igarashi O (2001) Alpha-Tocopherol affects the urinary and biliary excretion of 2,7,8-trimethy1-2 (2′-carboxyethyl)-6-hydroxychroman, gamma tocopherol metabolite, in rats. Lipids 36:467-472
37. Kliewer SA (2003) The nuclear pregnane X receptor regulates xenobiotic detoxification. J Nutr 133:2444S-2447S
38. Klipstein-Grobusch K, Geleijnse JM, den Breeijen JH, Boeing H, Hofman A, Grobbee DE, Witteman JC (1999) Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam study. Am J Clin Nutr 69:261-266
39. Kluth D, Landes N, Pfluger P, Müler-Schmehl K, Weiss K, Bumke-Vogt C, Ristow M, Brigelius-Flohé R (2005) Modulation of CYP3a11 expression by α-tocopherol but not γ-tocotrienol in mice. Free Rad Biol Med 38:507-514
40. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A (1994) Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 139:1180-1189
41. Kontush A, Finckh B, Karten B, Kohlschütter A, Beisiegel U (1996) Antioxidant and prooxidant activity of α-tocopherol in human plasma and low density lipoprotein. J Lipid Res 37:1436-1448
42. Krishnan K, Campbell S, Stone WL (2005) Comment on: high-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med 143:151 author reply 156-158
43. Kritharides L, Stocker R (2002) The use of antioxidant supplements in coronary heart disease. Atherosclerosis 164:211-219
44. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM (1996) Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 334:1156-1162
45. Landes N, Pfluger P, Kluth D, Birringer M, Ruhl R, Bol GF, Glatt H, Brigelius-Flohé R (2003) Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharmacol 65:269-273
46. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE (2005) Vitamin E in the primary prevention of cardiovascular disease and cancer: the women's health study: a randomized controlled trial. JAMA 294:56-65
47. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102:1016-1023
48. Lemcke-Norojärvi M, Kamal-Eldin A, Appelqvist LA, Dimberg LH, Öhrvall M, Vessby B (2001) Corn and sesame oils increase serum gamma-tocopherol concentrations in healthy Swedish women. J Nutr 131:1195-1201
49. Lim WS, Liscic R, Xiong C, Morris JC (2005) Comment on: high-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med 143:152 author reply 156-158
50. Liu S, Lee IM, Song Y, Van Denburgh M, Cook NR, Manson JE, Buring JE (2006) Vitamin E and risk of type 2 diabetes in the women's health study randomized controlled trial. Diabetes 55:2856-2862
51. Losonczy KG, Harris TB, Havlik RJ (1996) Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the established populations for epidemiologic studies of the elderly. Am J Clin Nutr 64:190-196
52. Marchioli R, Levantesi G, Macchia A, Marfisi RM, Nicolosi GL, Tavazzi L, Tognoni G, Valagussa F (2006) Vitamin E increases the risk of developing heart failure after myocardial infarction: results from the GISSI-Prevenzione trial. J Cardiovasc Med (Hagerstown) 7:347-350
53. Marras C, Lang AE, Oakes D, McDermott MP, Kieburtz K, Shoulson I, Tanner CM, Fahn S (2005) Comment on: high-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med 143:152-153 author reply 156-158
54. Meydani SN, Leka LS, Fine BC, Dallal GE, Keusch GT, Singh MF, Hamer DH (2004) Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. JAMA 292:828-836
55. Meydani SN, Lau J, Dallal GE, Meydani M (2005) Comment on: high-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med 143:153 author reply 156-158
56. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142:37-46
57. Morinobu T, Yoshikawa S, Hamamura K, Tamai H (2003) Measurement of vitamin E metabolites by high-performance liquid chromatography during high-dose administration of alpha-Tocopherol. Eur J Clin Nutr 57:410-414
58. Mustacich DJ, Leonard SW, Devereaux MW, Sokol RJ, Traber MG (2006) Alpha-Tocopherol regulation of hepatic cytochrome P450s and ABC transporters in rats. Free Rad Biol Med 41:1069-1078
59. Nell S, Bahtz R, Bossecker A, Kipp A, Landes N, Bumke-Vogt C, Halligan E, Lunec J, Brigelius-Flohé R (2007) PCR-verified microarray analysis and functional in vitro studies indicate a role of α-tocopherol in vesicular transport. Free Rad Res, in press
60. Nelson DR (1999) Cytochrome P450 and the individuality of species. Arch Biochem Biophys 369:1-10
61. Parker RS, Sontag TJ, Swanson JE (2000) Cytochrome P4503A-dependent metabolism of tocopherols and inhibition by sesamin. Biochem Biophys Res Commun 277:531-534
62. Pfluger P, Kluth D, Landes N, Bumke-Vogt C, Brigelius-Flohé R (2004) Vitamin E: underestimated as an antioxidant. Redox Rep 9:249-25463
63. Pharn DQ, Plakogiannis R (2005) Vitamin E supplementation in cardiovascular disease and cancer prevention: part 1. Ann Pharmacother 39:1870-1878
64. Possolo AM (2005) Comment on: high-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med 143:154 author reply 156-158
65. Quattrochi LC, Guzelian PS (2001) Cyp3A regulation: from pharmacology to nuclear receptors. Drug Metabol Dispos 29:615-622
66. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC (1993) Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450-1456
67. Salonen JT, Nyyssonen K, Salonen R, Lakka HM, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Lakka TA, Rissanen T, Leskinen L, Tuomainen TP, Valkonen VP, Ristonmaa U, Poulsen HE (2000) Antioxidant supplementation in atherosclerosis prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3 year progression of carotid atherosclerosis. J Intern Med 248:377-386
68. Salonen RM, Nyyssonen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen TH, Tuomainen TP, Valkonen VP, Ristonmaa U, Lakka HM, Vanharanta M, Salonen JT, Poulsen HE (2003) Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the antioxidant supplementation in atherosclerosis prevention (ASAP) study. Circulation 107:947-953
69. Shekelle PG, Morton SC, Jungvig LK, Udani J, Spar M, Tu W, Suttorp MJ, Coulter I, Newberry SJ, Hardy M (2004) Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med 19:380-389
70. Sontag TJ, Parker RS (2002) Cytochrome P450 omega hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem 277:25290-25296
71. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC (1993) Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328:1444-1449
72. Steinberg D, Witztum JL (2002) Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 105:2107-2111
73. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet 347:781-786
74. Traber MG, Elsner A, Brigelius-Flohé R (1998) Synthetic as compared with natural vitamin E is preferentially excreted as alpha-CEHC in human urine: studies using deuterated Ω-tocopheryl acetates. FEBS Lett 437:145-148
75. Traber MG, Siddens LK, Leonard SW, Schock B, Gohil K, Krueger K, Cross CE, Williams D (2005) α-Tocopherol modulates Cyp3a expression increases γ-CEHC production, and limits tissue γ-tocopherol accumulation in mice fed high γ-tocopherol diets. Free Rad Biol Med 38:773-785
76. Traber MG (2006) How much vitamin E?...Just enough! Am J Clin Nutr 84:959-960
77. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol, EJ (2003) Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361:2017-2023
78. Ward NC, Wu JH, Clarke MW, Puddey IB, Burke V, Croft KD, Hodgson JM (2007) The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Hypertens 25:227-234
79. Wright ME, Lawson KA, Weinstein SJ, Pietinen P, Taylor PR, Virtamo J, Albanes D (2006) Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the omega-Tocopherol, beta-Carotene cancer prevention study. Am J Clin Nutr 84:1200-1207
80. Zingg JM, Azzi A (2004) Non-antioxidant activities of vitamin E. Curr Med Chem 11:1113-1133